ANTIBODY DIVERSITY GENERATION
    21.
    发明申请
    ANTIBODY DIVERSITY GENERATION 失效
    抗体多样性生成

    公开(公告)号:US20080207459A1

    公开(公告)日:2008-08-28

    申请号:US12026412

    申请日:2008-02-05

    摘要: Methods for improving antibodies by a variety of DNA diversification and selection procedures are provided. Improvements include increases in affinity, alterations in specificity and effector function, as well as reduced antigenicity, e.g. humanization. Libraries of recombinant antibody sequences are provided, as are cells expressing members of such libraries. Novel phage display vectors are provided. Methods for the coevolution of an antibody and its cognate antigen are provided. Coevolution is used to evolve HIV envelope proteins with increased antigenicity and broadly neutralizing antibodies that interact therewith. Methods of improving antibodies for use in the detection of biological warfare agents are provided.

    摘要翻译: 提供了通过多种DNA多样化和选择程序改进抗体的方法。 改善包括亲和力的增加,特异性和效应子功能的改变,以及降低的抗原性,例如。 人性化。 提供重组抗体序列的文库,以及表达这些文库成员的细胞。 提供了新的噬菌体展示载体。 提供了抗体及其同源抗原共转化方法。 共转化用于发展具有增加的抗原性的HIV包膜蛋白和与之相互作用的广泛中和抗体。 提供了改进用于检测生物战剂的抗体的方法。

    Antibody diversity generation
    29.
    发明授权
    Antibody diversity generation 失效
    抗体多样性生成

    公开(公告)号:US08252727B2

    公开(公告)日:2012-08-28

    申请号:US12026412

    申请日:2008-02-05

    摘要: Methods for improving antibodies by a variety of DNA diversification and selection procedures are provided. Improvements include increases in affinity, alterations in specificity and effector function, as well as reduced antigenicity, e.g. humanization. Libraries of recombinant antibody sequences are provided, as are cells expressing members of such libraries. Novel phage display vectors are provided. Methods for the coevolution of an antibody and its cognate antigen are provided. Coevolution is used to evolve HIV envelope proteins with increased antigenicity and broadly neutralizing antibodies that interact therewith. Methods of improving antibodies for use in the detection of biological warfare agents are provided.

    摘要翻译: 提供了通过多种DNA多样化和选择程序改进抗体的方法。 改善包括亲和力的增加,特异性和效应子功能的改变,以及降低的抗原性,例如。 人性化。 提供重组抗体序列的文库,以及表达这些文库成员的细胞。 提供了新的噬菌体展示载体。 提供了抗体及其同源抗原共转化方法。 共转化用于发展具有增加的抗原性的HIV包膜蛋白和与之相互作用的广泛中和抗体。 提供了改进用于检测生物战剂的抗体的方法。